AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00303849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00303849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mannitol
Description: Given IA
Study NCT00303849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given IA
Study NCT00303849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT00303849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Thiosulfate
Description: Given IV
Study NCT02842658 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: A high-intensity interval exercise group
Description: To avoid or reduce muscle soreness or cramps, adequate warm-up is suggested
Study NCT02636829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: QALCIMUM questionnaire
Description: All patients will fill out the QALCIMUM questionnaire.
Study NCT02636829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Determination of calcium intake by a dietician interview
Description: All patients will have an interview with a dietician who performs a food survey serving as a reference (gold standard) and based on data from CIQUAL \*.~\* CIQUAL Data: Nutritional food composition table available on the website of the ANSES (National Agency for Sanitary Security of Food, Environment and Labour), published by the Observatory of the Nutritional Quality of Foods. This table includes 1500 sheets of 58 nutritional components. The data is integrated into the software (DATAMEAL) for calculating the ingesta parameters at the Nîmes University Hospital.
Study NCT01388452 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Point of care HIV RNA PCR
Description: The intervention is a HIV RNA PCR test for which UNC Project laboratory personnel will process samples in 48 hours so that patients can receive results prior to hospital discharge.
Study NCT00075686 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: Loading dose: Cetuxiumab 400mg/m2, IV on Day 1 (cycle 1 only). Weekly maintenance: Cetuximab 250mg/m2, IV on Days 8,15,22 of cycle 1 \& days 1,8,15,22 of all subsequent cycles
Study NCT00075686 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine hydrochloride
Description: 1000mg/m2 IV over 30 minutes
Study NCT01684059 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: zinc sulfate
Description: every participant took two capsules of zinc sulfate per day for three months (each one 220mg)
Study NCT03011060 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neo-adjuvant Chemotherapy
Description: A preoperative chemotherapy based on anthracyclines and taxanes.
Study NCT03011060 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Capecitabine 1000mg/m2 tablets twice a day for 8 cycles.
Study NCT02371928 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neuromuscular exercise program
Description: Exercises can be individually progressed from basic to elite level.~Low load exercises are performed every day with 2 sets of 20-25 repetitions whereas high load exercises are performed three times per week with 2 sets of 8-12 repetitions.~Exercises are progressed using the following components: arm-position, load, speed, open/closed eyes, stable/unstable surfaces.~Patients have online access to instructions and video recordings of all exercises and progression levels. Patients are trained to continuously evaluate their own shoulder function and to adjust the exercise levels themselves at home.~Supervision will be given two times a week for the first two weeks and then once a week for the remaining period.
Study NCT02371928 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard home exercise program
Description: Strengthening of the rotator cuff muscles are performed with the use of elastic bands (shoulder internal and external rotation besides abduction in scapular plane) whereas mobility/strengthening exercise for the scapular muscles are performed through weight-bearing positions and movements of the upper extremity.~All exercises are performed three times a week with 2 sets of 10 repetitions.
Study NCT03091257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib
Description: Administered Orally BID
Study NCT02842658 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: An Attention-Control Group
Description: Patients will be contacted weekly to access physical activity. To avoid or reduce muscle soreness or cramps, adequate warm-up is suggested
Study NCT04461756 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PPP001
Description: inhalation (vape)
Study NCT02824432 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-085
Description: TAK-085 capsules
Study NCT01267838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCI
Description: PCI of bifurcation lesions with double stenting
Study NCT02793427 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: blood sample collection
Study NCT03049436 — intervention group
Intervention type: OTHER
Intervention: Program of adapted physical activity
Study NCT01348087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFQ056
Description: The investigational drug, AFQ056, will be provided as hard gelatin capsules. Two different oral dosage strengths, identical in appearance, will be used.
Study NCT01532232 — intervention group
Intervention type: DRUG
Intervention: placebo
Description: Pts will receive the standard 12-week dosing regimen consisting of 1 mg po of study drug twice daily for 11 weeks,along with smoking cessation counseling, for 11 weeks with an initial dose titration to full strength during the 1st week as follows: 0.5 mg po once daily for 3 days titrated to 0.5mg po twice daily for 4 days. 154 pills will be supplied for the 12 week tx. In order to compensate for any accidentally dropped or lost pills during the study duration, a total of 175 pills will be given to the patient. Along with smoking cessation counseling, for 11 weeks. Pts will receive their medication from the MSK Pharmacy \& equivalent dosing \& side effect education from our Tobacco Cessation Nurse Practitioner. Tx with the study drug will begin after the initial counseling session. Physicians \& tobacco cessation nurses will be blinded regarding pts' assignment to medication or placebo tx arm. Likewise, pts will not be informed as to which medication condition they have been assigned.
Study NCT01532232 — intervention group
Intervention type: DRUG
Intervention: varenicline
Description: Pts will receive the standard 12-week dosing regimen consisting of 1 mg po of study drug twice daily for 11 weeks,along with smoking cessation counseling, for 11 weeks with an initial dose titration to full strength during the 1st week as follows: 0.5 mg po once daily for 3 days titrated to 0.5mg po twice daily for 4 days. 154 pills will be supplied for the 12 week tx. In order to compensate for any accidentally dropped or lost pills during the study duration, a total of 175 pills will be given to the patient. Along with smoking cessation counseling, for 11 weeks. Pts will receive their medication from the MSK Pharmacy \& equivalent dosing \& side effect education from our Tobacco Cessation Nurse Practitioner. Tx with the study drug will begin after the initial counseling session. Physicians \& tobacco cessation nurses will be blinded regarding pts' assignment to medication or placebo tx arm. Likewise, pts will not be informed as to which medication condition they have been assigned.
Study NCT02023372 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: NuCel with Autograft
Description: NuCel is a minimally manipulated allograft product derived from amniotic membrane along with cells from amniotic fluid. Local autograft is bone that comes from the patient's own vertebrae and surrounding bony structures.
Study NCT02785978 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levodopa acute challenge
Description: Inclusion visit (simultaneous video + ActiMyo recording):~Levodopa acute challenge and 2 hours of recording and medical monitoring
Study NCT02785978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled environment tests (series of tasks of everyday life)
Description: Inclusion visit (simultaneous video + ActiMyo recording):~Controlled environment tests (series of tasks of everyday life)
Study NCT02785978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standardized scales: MDS-UPDRS (Part II to IV) and RDRS
Description: Inclusion visit (simultaneous video + ActiMyo recording):~Standardized scales: MDS-UPDRS (Part II to IV) and RDRS
Study NCT02785978 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ActiMyo recording
Description: Continuous activity recording with ActiMyo during the 2 weeks of study participation
Study NCT02785978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diary completion
Description: Daily patient logbook completion during the 2 weeks of study participation
Study NCT03503773 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alcohol
Description: Alcohol is directly infused/delivered to the adventitial and periadventitial space of the renal arteries
Study NCT03503773 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham control
Description: endovascular, renal angiography
Study NCT03603418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone Sodium Phosphate
Description: Dexamethasone is a synthetic glucocorticoid that is commonly used in human medical practice as potent anti-inflammatory, immunosuppressive and analgesic agent.
Study NCT03603418 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Distilled water
Description: Distilled water
Study NCT03620929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol Valerate
Description: In all cases hormone therapy will be started from the day of operation, consisting of estradiol valerate at a dose of 4mg/d for 21 days, with the addition of dydrogesterone at a dose of 10 mg/d for the last 7 days of the estrogen therapy. After the withdrawal bleed, the hormone therapy will be repeated for another cycle. Second-look hysteroscopy will be carried out in the early proliferative phase, 4 weeks after the initial operation; a third-look hysteroscopy will be carried out 8 weeks after the initial operation. After assessment of the extent and severity of any reformed adhesion, hysteroscopic adhesiolysis will be carried out at the time of the second-look or third-look procedure, if adhesion had recurred.
Study NCT00782639 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iopamidol injection 76%
Description: Iopamiro-370 (Iopamidol injection 76%) is provided in single dose bottles/vials, ready to use, aqueous, nonpyrogenic, colorless to pale yellow sterile solution
Study NCT00782639 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: iodixanol
Description: Visipaque 320 (iodixanol) injection is provided in bottles/flexible containers, ready to use sterile, pyrogen-free colorless to pale yellow solution
Study NCT03183024 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: benralizumab
Description: open-label treatment
Study NCT03183024 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: sterile water to mimic benralizumab
Study NCT02621593 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: M22-IPL
Description: The IPL hand piece operates at a spectrum of 400-1200nm with 7 different filters that can be easily inserted to the hand piece to treat different conditions. The IPL hand piece also includes 2 different sapphire cooled light guides of 8x15mm and 15x35mm. The cut-off filters that will be used for this evaluation are filters blocking wavelengths of 560 and 595 nm.
Study NCT04743128 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The experimental group started an exercise program to achieve 65% to 80% of the maximum heart rate by using a pulsometer that measured the heart rate in order to get to the moderate intensity activity goal. The exercise session was 60 minutes long, three times per week, completing 180 minutes per week of moderate intensity exercise, for 12 weeks in total.
Study NCT00281918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Intravenous repeating dose
Study NCT00281918 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Intravenous repeating dose
Study NCT00281918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Intravenous repeating dose
Study NCT00281918 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludarabine Phosphate
Description: Intravenous repeating dose
Study NCT00281918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine Phosphate
Description: Intravenous repeating dose
Study NCT03964285 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rumination induction
Description: The induction method is based on specific instructions given to participants on how to focus on different elements of their experience. For example, they will be led, in the rumination condition, to reflect on the causes, meanings and consequences of the amount of tension they feel in their muscles.
Study NCT03964285 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: distraction induction
Description: The induction method is based on specific instructions given to participants on how to focus on different elements of their experience. In the distraction condition they will, for example, imagine a ship crossing the Atlantic.
Study NCT04168814 — intervention group
Intervention type: OTHER
Intervention: Observational test
Description: Nutritional risk (NutriScore), based on weight, weight loss, tumor location, and treatment, Nutritional status (VGS, Global Subjective Assessment Valoración Global Subjetiva, in Spanish), ECOG performance status; nutritional therapy (oral nutritional supplements, enteral nutrition, parenteral nutrition, dietary advice); type of treatment: chemo, type of chemo, adjuvant, neoadjuvant, palliative, curative endocrine therapy, targeted therapy +-immunotherapy vs QQT/RT therapy; cancer site. Covid-19 diagnosis.
Study NCT03917329 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ACT and PBS group workshop
Description: Acceptance and Commitment Therapy and Positive Behaviour Support Group Workshop. Three sessions of approximately three hour duration. Groups will consist of 5-10 parents or 5-10 members of education staff. The group will include both didactic and experiential elements.
Study NCT02157493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arrowhead Business Group Curriculum
Description: Arrowhead Business Group (ABG) is a culturally tailored entrepreneurship/life-skills intervention, which features instruction from American Indian paraprofessionals in an effort to decrease drug use, depressive symptoms, hopelessness and other high-risk behaviors among youth while improving their school performance and college/career aspirations.
Study NCT02157493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recreational League Control Condition
Description: The control condition will consist of a recreational sports league that will be led by local American Indian study staff who are experienced with Johns Hopkins camps and community-based Apache sports programs. Activities will be conducted on 3 Saturdays during the academic year to mixed gender groups of approximately 50 participants.
Study NCT02157493 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Recreational League Control Condition
Description: The control condition will consist of a recreational sports league that will be led by local American Indian study staff who are experienced with Johns Hopkins camps and community-based Apache sports programs. Activities will be conducted on 3 Saturdays during the academic year to mixed gender groups of approximately 50 participants.
Study NCT04784741 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional static hamstring muscle stretching
Description: Static stretching protocol had 10 repetitions in total with 15 seconds stretch time and 30 seconds relaxing time of hamstring muscle.
Study NCT04784741 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low amplitude whole body vibration therapy
Description: Given five sessions of low amplitude whole body vibration therapy for duration of 10 minutes, on alternative days, along with static stretching of hamstring muscles.~Static stretching protocol had 10 repetitions in total with 15 seconds stretch time and 30 seconds relaxing time of hamstring muscle.
Study NCT04784741 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Biodex Balance System
Description: Pre and post balance assessment by Biodex balance system
Study NCT04784741 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biodex Balance System
Description: Pre and post balance assessment by Biodex balance system
Study NCT04784741 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Range of motion of hamstring muscle
Description: Straight Leg Raising to check pre and post Range of Motion by using Goniometer
Study NCT04784741 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Range of motion of hamstring muscle
Description: Straight Leg Raising to check pre and post Range of Motion by using Goniometer
Study NCT01457222 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness intervention
Description: Web-based guided mindfulness meditation 10 minutes daily
Study NCT01457222 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Music relaxation
Description: Music relaxation 10 minutes daily
Study NCT04464057 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: early oral feeding or early enteral nurtrion
Description: The patients in the experimental group were fed orally within 24-48 hours after intestinal anastomosis. Start taking it at 24-48 hours after surgery until discharged. The initial dose is 1ml/kg.h, which is gradually increased to 100ml/kg daily.
Study NCT00995709 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AIN457
Study NCT00995709 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02113163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin Eicosapentaenoate
Study NCT02113163 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin HCl and Vascepa
Study NCT02828683 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PCI in patients with ST-elevation myocardial infarction
Description: Percutaneous coronary intervention in patients with ST segment elevation myocardial infarction (STEMI)
Study NCT02828683 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PCI in patients with ST-elevation myocardial infarction
Description: Percutaneous coronary intervention in patients with ST-segment elevatio myocardial infarction
Study NCT03781804 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: OPN-375
Description: OPN-375, BID
Study NCT01660204 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Preferred empirical treatment
Description: The investigators are using a cluster-randomized cross-over design for preferred empirical treatment. One of the 3 treatment arms is used as preferred empirical therapy during a period of 4 consecutive months, after which preferred treatment will rotate to 1 of the other 2 regimens. The order of change is randomised per hospital, thereby controlling for inter-hospital variables and minimizing seasonal influences.
Study NCT03781804 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: OPN-375
Description: OPN-375, BID
Study NCT03128827 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAM sensor
Description: Acoustic Respiration Monitor
Study NCT02364921 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Two multilayer compression bandage
Description: Usual clinical practice in venous ulcer in wound care in assessing, cleaning, desinfection, debridement and topical treatment.~Compression therapy: a multilayer compression bandage with two layers, suitable for the treatment of venous leg ulcers and to reduce edema chronic venous be used. Apply one two seven days
Study NCT02364921 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Crepe bandage
Description: Crepe bandage: Usual clinical practice in venous ulcer in wound care. crepe bandage apply one to seven days
Study NCT00768066 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous human mesenchymal cells (hMSCs)
Description: Participants will receive 40 million cells/mL delivered in either a dose of 0.25 mL per injection for a total of 1 x 108 (100 million) hMSCs x 10 injections or a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.
Study NCT00768066 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous human bone marrow cells (hBMCs)
Description: Participants will receive 40 million cells/mL delivered in either a dose of 0.25 mL per injection for a total of 1 x 108 (100 million) hBMCs x 10 injections or a dose of 0.5 mL per injection for a total of 2 x 108 (200 million) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.
Study NCT00768066 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive 0.5 mL injections of phosphate-buffered saline (PBS) and 1% human serum albumin (HAS) x 10 injections. The injections will be administered transendocardially during cardiac catheterization using the Biocardia Helical Infusion Catheter.